CMS offers guidance in billing Medicare for COVID-19 antibody treatment

CMS, through a FAQ and infographic, is trying to clear up Medicare billing for COVID-19 antibody therapy treatment.
The agency is covering monoclonal antibody therapies at no cost for a broad range of providers and suppliers.
 

Read the full post on News Feed

smorse